Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
anti-Vaspin (human), mAb (VP63)
1: Human vaspin (His-tagged).
2: Human vaspin (FLAG®-tagged).
3: Mouse IL-33 (His-tagged) (negative control).
Product Details | |
---|---|
Synonyms | Visceral Adipose Tissue-derived Serine Protease Inhibitor; Serpin A12; OL-64 |
Product Type | Monoclonal Antibody |
Properties | |
Clone | VP63 |
Isotype | Mouse IgG1κ |
Immunogen/Antigen | Recombinant human vaspin. |
Application |
ELISA: (direct or indirect: 1:2'000-1:5'000) |
Crossreactivity | Human |
Specificity |
Recognizes human vaspin. Detects a band of ~48kDa by Western blot. |
Purity Detail | Protein G-affinity purified. |
Concentration | 1mg/ml |
Formulation | Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. |
Isotype Negative Control | |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Vaspin (Visceral adipose tissue-derived serpin; Serpin A12), a serine protease inhibitor (serpin), is an insulin-sensitizing adipocytokine that has been isolated from both visceral and subcutaneous white adipose tissue. Based on recent findings, vaspin is suggested to regulate immune responses and inflammation and was found to be correlated with various metabolic parameters. Vaspin may represent a novel biomarker for obesity and impaired insulin sensitivity and might serve as a new therapeutic target of metabolic syndrome.
- Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects: N. Klöting, et al.; Diabetologia 54, 1819 (2011)
- Untersuchungen zur Rolle von Vaspin in der Psoriasis: K. Rall; Diss. Universität Leipzig (2012) (IHC protocol)